MedAustron: New hope in the fight against cancer with innovative therapy

MedAustron: New hope in the fight against cancer with innovative therapy

The MedAustron in Wiener Neustadt sets new standards with innovative cancer therapy! Since its founding in 2016, the Center for Ion Therapy and Research has become one of the leading facilities in the world treating patients with protons and carbon ions. In an impressive press conference today, the successes of previous treatments, which have already reached over 2,700 patients, as well as new development opportunities were presented. Particularly noteworthy is the successful proton treatment of the first patient with uveal melanoma in November 2024, which has significantly expanded MedAustron's treatment spectrum. “We offer high-precision treatment that enables patients to receive treatment directly here in Lower Austria without having to travel long distances,” emphasized Deputy Governor Stephan Pernkopf during the event, as reported by ots.at reported.

Growth and expansion of MedAustron

To date, 2,000 patients have already consulted MedAustron with its unique ion therapy, and the success rate is promising. The positive patient reaction and the results of clinical studies demonstrate the effectiveness of the therapy, which specializes in the treatment of head and neck tumors, among other things. Further interesting developments lie ahead as MedAustron plans to integrate new therapeutic approaches for diseases such as pancreatic, liver and lung cancer. The researchers are also focusing on strengthening the patient's own immune system through targeted radiation applications, which could further increase therapy efficiency. Loud medaustron.at An independent therapy room will also be added in the future to expand capacity and accommodate the increased treatment volumes. The opening is planned for 2026.

The combined efforts of over 250 employees from more than 20 nations ensure that MedAustron plays a central role in oncological treatment both in Austria and internationally. The center is an important partner in Europe and attracts patients from many surrounding countries because the same radiation treatment is not yet available there. The continuous development and innovative approaches in the therapeutic process not only create hope for sick patients, but also ensure that these medical advances remain highly accessible, benefiting the entire community and allowing those affected to fight their serious illness with confidence.